For HER2/ERBB2, ER/ESR1, and PGR genes in BC and for PDL1 gene in LC, we demonstrated high and statistically significant correlations between the RNA sequencing (Oncobox protocol) and immunohistochemical measurements. The gene discussed is ERBB2; the disease is breast cancer.